| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.055 | 0.8 |